Shareholding disclosure

Basilea Pharmaceutica AG

Declared position

14.75%

Threshold

Crossed downwards

Timeline

Published

05.11.2013

Transaction

31.10.2013

Voting rights breakdown

Voting rights acquired0%
Voting rights sold14.75%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TADB400033

Beneficial owner

Basilea Pharmaceutica AG

Declared address

Basilea Pharmaceutica AG, 4005 Basel

Durch die Ausübung/Exersale von Mitarbeiteroptionen gemäss Optionsplan, welche zum Erwerb von Namenaktien der Basilea Pharmaceutica AG (Basiswert, Bezugsverhältnis 1:1) oder entsprechendem Cash Settlement berechtigen, wurde der Grenzwert von 15% unterschritten.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open